RU2018122958A - Способ лечения состояний печени путем трансплантации стволовых клеток в стенки желчных протоков - Google Patents
Способ лечения состояний печени путем трансплантации стволовых клеток в стенки желчных протоков Download PDFInfo
- Publication number
- RU2018122958A RU2018122958A RU2018122958A RU2018122958A RU2018122958A RU 2018122958 A RU2018122958 A RU 2018122958A RU 2018122958 A RU2018122958 A RU 2018122958A RU 2018122958 A RU2018122958 A RU 2018122958A RU 2018122958 A RU2018122958 A RU 2018122958A
- Authority
- RU
- Russia
- Prior art keywords
- cells
- liver
- suspension
- walls
- growth factor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/407—Liver; Hepatocytes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
- A61L27/3834—Cells able to produce different cell types, e.g. hematopoietic stem cells, mesenchymal stem cells, marrow stromal cells, embryonic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3886—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells comprising two or more cell types
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
- A61L2300/414—Growth factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/28—Materials or treatment for tissue regeneration for liver reconstruction
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Cell Biology (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Botany (AREA)
- Developmental Biology & Embryology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Neurology (AREA)
- Materials For Medical Uses (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
Claims (16)
1. Способ лечения дисфункции или состояния печени, включающий
(a) получение суспензии печеночных стволовых клеток/клеток-предшественников; и
(b) введение этой суспензии в стенки или на стенки билиарного дерева субъекту с дисфункцией или состоянием печени; где значительная часть клеток приживается в стенке билиарного дерева,
где эти клетки созревают, становясь функциональными клетками печени, и мигрируют в печень, тем самым осуществляя лечение дисфункции или состояния печени.
2. Способ по п.1, в котором клетки являются стволовыми клетками билиарного дерева или стволовыми клетками печени, или коммитированными клетками-предшественниками, происходящими от указанных стволовых клеток.
3. Способ по п.1, в котором суспензию объединяют с одним или несколькими биологическими материалами для образования матриксного комплекса.
4. Способ по п.3, в котором один или несколько биологических материалов включают коллагены, молекулы адгезии, протеогликаны, гиалуронаны, цепи гликозаминогликанов, хитозан, альгинат и синтетические, биодеградируемые и биологически совместимые полимеры, или их комбинации.
5. Способ по п.4, в котором факторы роста могут включать одно или несколько из следующих веществ: факторы роста фибробластов (FGF), R-спондин, фактор роста гепатоцитов (HGF), эпидермальный фактор роста (EGF), фактор роста эндотелия сосудов (VEGF), инсулиноподобный фактор роста I (IGF-1), инсулиноподобный фактор роста II (IGF-2), онкостатин-M, фактор, ингибирующий лейкоз (LIF), трансферрин, инсулин, глюкокортикоиды, гормоны роста, эстрогены, андрогены, гормоны щитовидной железы, гормоны гипофиза и комбинации этих веществ.
6. Способ по п.1, в котором суспензию комбинируют с факторами роста, дополнительными клетками, или их комбинациями.
7. Способ по п.1, в котором клетки получают из здорового или функционального участка билиарного дерева субъекта.
8. Способ по п.1, в котором клетки получают из билиарного дерева не-аутологичного донора.
9. Способ по п.1, в котором суспензию вводят путем лапароскопического хирургического вмешательства или путем эндоскопии.
10. Способ по п.1, в котором суспензию клеток вводят путем инъекции, в качестве пластыря с биодеградируемым покрытием, или в губке.
11. Способ восстановления функций печени у субъекта с заболеванием или дисфункцией печени, включающий
(а) получение суспензии печеночных стволовых клеток/клеток-предшественников; и
(b) введение этой суспензии в стенки или на стенки желчных протоков поблизости от печени субъекта; и где значительная часть введенных клеток приживается по меньшей мере в части или на части печени в виде зрелых печеночных клеток in vivo.
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361780644P | 2013-03-13 | 2013-03-13 | |
| US61/780,644 | 2013-03-13 | ||
| US14/207,191 | 2014-03-12 | ||
| US14/207,191 US9533013B2 (en) | 2013-03-13 | 2014-03-12 | Method of treating pancreatic and liver conditions by endoscopic-mediated (or laparoscopic-mediated) transplantation of stem cells into/onto bile duct walls of particular regions of the biliary tree |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015143617A Division RU2015143617A (ru) | 2013-03-13 | 2014-03-13 | Способ лечения состояний поджелудочной железы и печени путем трансплантации стволовых клеток в стенки желчных протоков |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2018122958A true RU2018122958A (ru) | 2019-03-06 |
Family
ID=51537508
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018122958A RU2018122958A (ru) | 2013-03-13 | 2014-03-13 | Способ лечения состояний печени путем трансплантации стволовых клеток в стенки желчных протоков |
| RU2015143617A RU2015143617A (ru) | 2013-03-13 | 2014-03-13 | Способ лечения состояний поджелудочной железы и печени путем трансплантации стволовых клеток в стенки желчных протоков |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2015143617A RU2015143617A (ru) | 2013-03-13 | 2014-03-13 | Способ лечения состояний поджелудочной железы и печени путем трансплантации стволовых клеток в стенки желчных протоков |
Country Status (18)
| Country | Link |
|---|---|
| US (2) | US9533013B2 (ru) |
| EP (2) | EP3733219B1 (ru) |
| JP (1) | JP2016513466A (ru) |
| KR (1) | KR20150130434A (ru) |
| CN (1) | CN105264065A (ru) |
| AU (1) | AU2014228310A1 (ru) |
| BR (1) | BR112015021453A8 (ru) |
| CA (1) | CA2904140C (ru) |
| CL (1) | CL2015002557A1 (ru) |
| CR (1) | CR20150543A (ru) |
| ES (2) | ES2848075T3 (ru) |
| HK (1) | HK1218430A1 (ru) |
| IL (1) | IL240934A0 (ru) |
| MX (1) | MX2015012120A (ru) |
| PH (1) | PH12015502034A1 (ru) |
| RU (2) | RU2018122958A (ru) |
| SG (2) | SG11201507285WA (ru) |
| WO (1) | WO2014143632A1 (ru) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104491931B (zh) * | 2014-12-02 | 2017-04-12 | 清华大学深圳研究生院 | 含有皮脂腺的皮肤组织及其形成方法和用途 |
| CN107636149A (zh) | 2015-04-03 | 2018-01-26 | 普罗帕格尼克斯公司 | 上皮细胞的离体增殖 |
| JP6869231B2 (ja) * | 2015-09-11 | 2021-05-12 | プロパジェニクス インコーポレイテッド | ｅｘ ｖｉｖｏでの上皮細胞の増殖 |
| US20200392465A1 (en) * | 2016-11-15 | 2020-12-17 | Regrow Biosciences Pvt. Ltd. | A process of preparing buccal epithelial cell suspension and its use |
| JP2020515544A (ja) * | 2017-03-25 | 2020-05-28 | ユニバーシティ オブ マイアミ | 治療細胞を含む生物学的足場 |
| AU2018282728A1 (en) | 2017-06-12 | 2020-01-30 | The University Of North Carolina At Chapel Hill | Patch graft compositions for cell engraftment |
| TW202002997A (zh) * | 2018-03-29 | 2020-01-16 | 北卡羅來納大學教堂山 | 來自十二指腸布隆納氏腺之幹細胞／前驅細胞及其分離和使用方法 |
| MX2021012314A (es) * | 2019-04-11 | 2021-11-12 | Univ Pittsburgh Commonwealth Sys Higher Education | Procedimiento de trasplante celular minimamente invasivo para inducir el desarrollo de organogenesis in vivo. |
| GB202102235D0 (en) * | 2021-02-17 | 2021-03-31 | Cambridge Entpr Ltd | Cell transplantation |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5861313A (en) * | 1995-06-07 | 1999-01-19 | Ontogeny, Inc. | Method of isolating bile duct progenitor cells |
| US6960576B2 (en) | 1999-09-13 | 2005-11-01 | Bristol-Myers Squibb Pharma Company | Hydroxyalkanoylaminolactams and related structures as inhibitors of Aβ protein production |
| JP2002171865A (ja) * | 2000-12-05 | 2002-06-18 | Kansai Tlo Kk | 内臓疾患実験動物モデル、その作製方法及びそれを用いた薬物の評価方法 |
| US20020155096A1 (en) | 2001-02-23 | 2002-10-24 | Chancellor Michael B. | Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair |
| US6805860B1 (en) * | 2001-09-30 | 2004-10-19 | Eckhard Alt | Method of transluminal application of myogenic cells for repair or replacement of heart tissue |
| HUE032238T2 (en) * | 2002-03-15 | 2017-09-28 | Univ North Carolina Chapel Hill | Primitive and proximal liver stem cells |
| ES2385248T3 (es) * | 2004-01-14 | 2012-07-20 | Novahep Ab | Células progenitoras hepáticas humanas y métodos de uso de las mismas |
| WO2007059501A2 (en) | 2005-11-16 | 2007-05-24 | University Of North Carolina At Chapel Hill | Extracellular matrix components for expansion or differentiation of hepatic progenitors |
| WO2007127698A2 (en) * | 2006-04-25 | 2007-11-08 | Board Of Supervisors Of Louisiana State Universityand Agricultural And Mechanical College | Adipose derived adult stem cells in hepatic regeneration |
| DK2428561T3 (en) | 2006-05-26 | 2019-01-21 | Univ North Carolina Chapel Hill | HEPATIC STELLATLE CELLS |
| WO2008101215A1 (en) * | 2007-02-16 | 2008-08-21 | Varian Medical Systems Technologies, Inc. | Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo |
| WO2008109659A2 (en) | 2007-03-06 | 2008-09-12 | University Of North Carolina At Chapel Hill | Complexes of hyaluronans, other matrix components, hormones and growth factors for maintenance, expansion and/or differentiation of cells |
| KR20100094970A (ko) | 2007-06-15 | 2010-08-27 | 유니버시티 오브 노스캐롤라이나 앳 채플 힐 | 중간엽 공급자 세포로부터의 파라크린 시그널 및 이를 이용한 간 전구세포의 확장 및 분화 조절 |
| WO2009111778A2 (en) * | 2008-03-07 | 2009-09-11 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Lymph nodes as a site for regeneration |
| US20120189702A1 (en) * | 2009-08-06 | 2012-07-26 | Albert Einstein College Of Medicine Of Yeshiva University | Cell therapy for treatment of liver failure |
| EP2471542B1 (en) * | 2009-08-28 | 2016-04-27 | Osaka Air Machine Service, Ltd. | Therapeutic agent for liver-related diseases |
| KR20200146043A (ko) | 2009-10-30 | 2020-12-31 | 더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 | 간외 담도계로부터의 다분화능 줄기 세포 및 이의 분리 방법 |
| WO2011068946A1 (en) * | 2009-12-02 | 2011-06-09 | Ramtin Agah | Devices, methods and kits for delivery of therapeutic materials to a pancreas |
| NZ630598A (en) | 2010-05-07 | 2016-02-26 | Univ North Carolina | Method of engrafting cells from solid tissues |
| CN103249404A (zh) | 2010-07-02 | 2013-08-14 | 北卡罗来纳-查佩尔山大学 | 生物基质支架 |
| WO2014059402A1 (en) * | 2012-10-12 | 2014-04-17 | The Johns Hopkins University | Human endocrine progenitors from adult pancreatic tissue |
-
2014
- 2014-03-12 US US14/207,191 patent/US9533013B2/en active Active
- 2014-03-13 ES ES14763985T patent/ES2848075T3/es active Active
- 2014-03-13 RU RU2018122958A patent/RU2018122958A/ru not_active Application Discontinuation
- 2014-03-13 EP EP20182376.2A patent/EP3733219B1/en active Active
- 2014-03-13 ES ES20182376T patent/ES2968686T3/es active Active
- 2014-03-13 CA CA2904140A patent/CA2904140C/en active Active
- 2014-03-13 MX MX2015012120A patent/MX2015012120A/es unknown
- 2014-03-13 JP JP2016502151A patent/JP2016513466A/ja active Pending
- 2014-03-13 RU RU2015143617A patent/RU2015143617A/ru unknown
- 2014-03-13 EP EP14763985.0A patent/EP2970879B1/en active Active
- 2014-03-13 KR KR1020157028213A patent/KR20150130434A/ko not_active Application Discontinuation
- 2014-03-13 SG SG11201507285WA patent/SG11201507285WA/en unknown
- 2014-03-13 SG SG10201707522RA patent/SG10201707522RA/en unknown
- 2014-03-13 WO PCT/US2014/026461 patent/WO2014143632A1/en active Application Filing
- 2014-03-13 BR BR112015021453A patent/BR112015021453A8/pt not_active Application Discontinuation
- 2014-03-13 CN CN201480013328.5A patent/CN105264065A/zh active Pending
- 2014-03-13 AU AU2014228310A patent/AU2014228310A1/en not_active Abandoned
-
2015
- 2015-08-31 IL IL240934A patent/IL240934A0/en unknown
- 2015-09-09 CL CL2015002557A patent/CL2015002557A1/es unknown
- 2015-09-10 PH PH12015502034A patent/PH12015502034A1/en unknown
- 2015-10-13 CR CR20150543A patent/CR20150543A/es unknown
- 2015-11-09 US US14/936,519 patent/US9750770B2/en active Active
-
2016
- 2016-06-06 HK HK16106438.9A patent/HK1218430A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2904140C (en) | 2023-10-17 |
| SG10201707522RA (en) | 2017-10-30 |
| CN105264065A (zh) | 2016-01-20 |
| KR20150130434A (ko) | 2015-11-23 |
| EP2970879B1 (en) | 2020-11-04 |
| US20160058798A1 (en) | 2016-03-03 |
| US20140301985A1 (en) | 2014-10-09 |
| EP3733219B1 (en) | 2023-11-01 |
| AU2014228310A1 (en) | 2015-10-08 |
| US9533013B2 (en) | 2017-01-03 |
| CA2904140A1 (en) | 2014-09-18 |
| BR112015021453A2 (pt) | 2017-07-18 |
| EP2970879A4 (en) | 2016-12-28 |
| EP3733219A1 (en) | 2020-11-04 |
| CL2015002557A1 (es) | 2016-08-26 |
| JP2016513466A (ja) | 2016-05-16 |
| EP2970879A1 (en) | 2016-01-20 |
| WO2014143632A1 (en) | 2014-09-18 |
| US9750770B2 (en) | 2017-09-05 |
| SG11201507285WA (en) | 2015-10-29 |
| IL240934A0 (en) | 2015-11-30 |
| ES2848075T3 (es) | 2021-08-05 |
| PH12015502034A1 (en) | 2016-01-18 |
| RU2015143617A (ru) | 2017-04-20 |
| CR20150543A (es) | 2016-02-24 |
| ES2968686T3 (es) | 2024-05-13 |
| RU2015143617A3 (ru) | 2018-03-22 |
| BR112015021453A8 (pt) | 2021-07-06 |
| MX2015012120A (es) | 2016-05-18 |
| HK1218430A1 (zh) | 2017-02-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2018122958A (ru) | Способ лечения состояний печени путем трансплантации стволовых клеток в стенки желчных протоков | |
| RU2736955C2 (ru) | Способ прививки клеток печени субъекту с заболеванием или дисфункцией печени | |
| James et al. | Tendon tissue engineering: adipose-derived stem cell and GDF-5 mediated regeneration using electrospun matrix systems | |
| Baiguera et al. | Endothelialization approaches for viable engineered tissues | |
| Joanne et al. | Nanofibrous clinical-grade collagen scaffolds seeded with human cardiomyocytes induces cardiac remodeling in dilated cardiomyopathy | |
| Park et al. | 3D printing technology to control BMP-2 and VEGF delivery spatially and temporally to promote large-volume bone regeneration | |
| Chung et al. | Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction | |
| Badylak et al. | RETRACTED: engineered whole organs and complex tissues | |
| Liu et al. | Biomimetic tendon extracellular matrix composite gradient scaffold enhances ligament-to-bone junction reconstruction | |
| Badylak | The extracellular matrix as a scaffold for tissue reconstruction | |
| Kenar et al. | A 3D aligned microfibrous myocardial tissue construct cultured under transient perfusion | |
| Pan et al. | In-vivo organ engineering: Perfusion of hepatocytes in a single liver lobe scaffold of living rats | |
| Neef et al. | Co-transplantation of mesenchymal stromal cells and induced pluripotent stem cell-derived cardiomyocytes improves cardiac function after myocardial damage | |
| AU2019271995B2 (en) | Method of engrafting cells from solid tissues | |
| Gholobova | Formation of endothelial networks in human tissue-engineered skeletal muscle | |
| RU2574364C2 (ru) | Способ трансплантации клеток из плотных тканей | |
| Jeffords | Tailoring Material Properties Of Cardiac Matrix Hydrogels For Cardiac Tissue Engineering | |
| BR122021002798B1 (pt) | Método de criopreservação de células |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20170314 |